OMRON Healthcare Co., Ltd. (hereinafter referred to as the Company) based in 
Muko, Kyoto Prefecture, has announced the official sponsorship of European 
Society of Cardiology Congress 2023 (hereinafter referred to as ESC Congress 
2023) via OMRON Healthcare Europe B.V., OMRON Healthcare's sales and marketing 
headquarters in Europe. The annual ESC congress, the world's largest congress 
on cardiovascular diseases, will be held from August 25 to 28, 2023, at the RAI 
Amsterdam in the Netherlands. The Company has been a partner for several years 
and, at this year's satellite symposium, it will introduce the correlation 
between hypertension and atrial fibrillation, which is known to cause 
cardiogenic embolism. At its booth, a set of innovative devices and services 
available in Europe will be showcased. 

Logo: https://kyodonewsprwire.jp/img/202308228313-O1-h8LhlZI4

Image: Exhibition booth (for illustration purposes only)
https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/202308228313/_prw_PI2lg_1IFJHtMm.jpg


Under the theme of "Revealing asymptomatic atrial fibrillation and hypertension 
in the fight against stroke," the satellite symposium will be chaired by Prof. 
Gerhard Hindricks of Charite University Hospital and discuss blood pressure 
control and early detection of atrial fibrillation. The symposium will also 
introduce the latest study on detecting atrial fibrillation recurrence after 
ablation at home as well as a technique of diagnosing atrial fibrillation in 30 
seconds and its advantages.

At the booth, the Company will present a set of innovative devices and 
services, including "Complete (TM)," an upper-arm blood pressure monitor with 
built-in ECG technology that can record ECG while monitoring blood pressure, 
and a portable ECG device that allows users to record an electrocardiogram 
whenever they feel unwell. "Viso," an OMRON Healthcare remote 
patient-monitoring service, will also be showcased at the booth. Viso is a 
service, currently available in the U.K., that allows patients to share vital 
data measured at home with their doctors in real time, enabling doctors to 
intervene in the hypertension management appropriately based on the patient's 
condition.

Aiming for zero cerebro-cardiovascular events, the Company has been working on 
advancing the ways of hypertension treatment in collaboration with healthcare 
professionals and researchers. The Company will continue to promote academic 
activities globally, develop devices and services, and contribute to empowering 
people worldwide to live life to the fullest.

ESC Congress 2023 event outline
- Title: European Society of Cardiology Congress 2023
- Date: August 25-28, 2023 (CEST)
- Venue: RAI Amsterdam
- Official website: https://www.escardio.org/Congresses-Events/ESC-Congress

Satellite symposium
- Date & time: 10:15 - 11:00 on Sunday, August 27, 2023 (CEST) 
- Room: Luxembourg lecture room
- Theme: Revealing asymptomatic atrial fibrillation and hypertension in the 
fight against stroke
- Chair: Prof. Gerhard Hindricks (Charite University Hospital - Berlin, Germany)

Session 1: 
Theme: How blood pressure control and early detection of atrial fibrillation 
can prevent strokes
Speaker: Prof. Gerhard Hindricks (Charite University Hospital - Berlin, Germany)

Session 2: 
Theme: Detecting atrial fibrillation recurrence after ablation at home
Speaker: Associate Prof. Keitaro Senoo (Kyoto Prefectural University of 
Medicine - Kyoto, Japan)

Session 3: 
Theme: Diagnosing atrial fibrillation in 30 seconds and its advantages
Speaker: Prof. Faizel Osman (University Hospitals of Coventry and Warwickshire 
NHS Trust - Coventry, United Kingdom of Great Britain & Northern Ireland)


Source: OMRON Healthcare Co., Ltd.